BookMyShow (BMS), the ticketing partner for the ICC Women’s ODI World Cup, has yet to open sales for the final match. Throughout the tournament, ticket prices have started from ...
Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...
Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol ...
The Open VSX registry rotated access tokens after they were accidentally leaked by developers in public repositories and allowed threat actors to publish malicious extensions in an attempted ...
With HRSA's approval of eight manufacturer rebate plans, hospitals enter the 60-day readiness period before the January 1, 2026, launch. DEERFIELD BEACH, Fla., Oct. 31, 2025 /PRNewswire/ -- The ...
Bristol Myers Squibb beat Wall Street estimates for third-quarter revenue on Thursday, as strong growth of its cancer ...
NXP Improves Battery Health Monitoring with EIS Capable Battery Management Chipset NXP brings lab-grade diagnostics into ...
TipRanks on MSN
Bristol-Myers Squibb’s New Study on BMS-986517: A Potential Game-Changer in Cancer Treatment
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
24/7 Wall St. on MSN
Uh Oh !! Cathie Wood Predicts “Reality Check” (Sell-off) – 5 High-Yield Dividend Safety Stocks
Following in the footsteps of David Solomon at Goldman Sachs and Jamie Dimon at JPMorgan, Ark Investments guru Cathie Wood ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback